Hypersensitivity Reactions to Cancer Chemotherapy: Practical Recommendations of ARADyAL for Diagnosis and Desensitization

Autor: María José Torres, Maria Del Carmen Dieguez, B. de la Hoz Caballer, M Fernández-Rivas, Arantza Vega, M P Berges-Gimeno, M Gandolfo-Cano, L Sánchez-Morillas, G Gastaminza-Lasarte, Eloína González-Mancebo, Rosa Muñoz-Cano, R. Barranco, Inmaculada Doña, Joan Bartra, T W Jimenez-Rodriguez

Publikováno v: JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

Rapid drug desensitization has enabled first-line therapies in patients with drug hypersensitivity reactions to chemotherapeutic drugs including monoclonal antibodies. Desensitization is a safe and highly effective procedure, not only for IgE-mediate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dede57926877cc67f32c357bfaff284
https://doi.org/10.18176/jiaci.0712

Does Rapid Drug Desensitization to Chemotherapy Affect Survival Outcomes?

Autor: M. P. Berges-Gimeno, Ricardo Madrigal-Burgaleta, V Pachon, L V Carpio-Escalona, R. Ferreiro-Monteagudo, Emilio Alvarez-Cuesta, L Bernal-Rubio, P. Lopez-Gonzalez, P Gehlhaar, F Longo-Muñoz

Publikováno v: Journal of Investigational Allergology and Clinical Immunology. 30:254-263

Background and objective Hypersensitivity reactions to oxaliplatin may affect prognosis by jeopardizing the timely completion of scheduled treatment sessions or by forcing reactive patients into unexpected changes in therapy. Rapid drug desensitizati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1582b1b43f0e368a372a94513586e5
https://doi.org/10.18176/jiaci.0425

Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment

Autor: Emilio Alvarez-Cuesta, D. Angel-Pereira, C. Pueyo, R. Ferreiro-Monteagudo, Carmen Guillén-Ponce, M. P. Berges-Gimeno, Ricardo Madrigal-Burgaleta, E. Gomez de Salazar

Publikováno v: Allergy. 68:853-861

Background Desensitization to antineoplastic agents is becoming a standard of care. Efforts to establish and improve these techniques are being made at many institutions. Our aims are to evaluate a new rapid desensitization protocol designed to be sh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cf38795a3367093c91bd70fe90f0f594
https://doi.org/10.1111/all.12105

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

Autor: Donald D. Stevenson, Ronald A. Simon, M P Berges-Gimeno

Publikováno v: Clinical & Experimental Allergy. 32:1491-1496

Background Leukotrienes (LTs) appear to be crucial mediators of aspirin (ASA)-induced lower respiratory tract reactions. Therefore, it is logical to assume that leukotriene-modifier drugs (LTMDs) might block these reactions. Objective The aim of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b312018c944b526212ec88358da8993
https://doi.org/10.1046/j.1365-2745.2002.01501.x

Rapid desensitization to chemotherapy and monoclonal antibodies is effective and safe

Autor: Joana Caiado, Emilio Alvarez-Cuesta, L. Pur Ozyigit, V. Mezzano, Mariana Castells, Ricardo Madrigal-Burgaleta, D. Angel-Pereira, M. P. Berges-Gimeno, M. Picard, Pedro Giavina-Bianchi

Publikováno v: Allergy. 68(11)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c713768fc91b55296e3dc15bc691e7
https://pubmed.ncbi.nlm.nih.gov/24498642